Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/10078
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSondhi, Sham M-
dc.contributor.authorDwivedi, Amrender Dhar-
dc.contributor.authorSingh, Jaiveer-
dc.contributor.authorGupta, P P-
dc.date.accessioned2010-08-20T05:27:03Z-
dc.date.available2010-08-20T05:27:03Z-
dc.date.issued2010-08-
dc.identifier.issn0975-0983(Online); 0376-4699(Print)-
dc.identifier.urihttp://hdl.handle.net/123456789/10078-
dc.description1076-1082en_US
dc.description.abstractCondensation of 2- and 4-picolylaminehydrochloride 2a,b with (un) substituted phenacylthiocyanate 1a-d gives 4-aryl-3-(2- or 4-picolyl)-2-imino-4-thiazolines 3a-h in moderate yields. Sulfonamide derivatives 4a-h have been synthesized by condensation of 4-aryl-3-(2- or 4-picolyl)-2-imino-4-thiazolines 3a-h with methanesulfonylchloride in good yields. Condensation of 2-cyanopyridine with thiazolines 3a, 3e and of 4-cyanopyridine with 3a, c, e and h gives amidine derivatives 5a, b and 6a-d respectively. Thiazoline derivatives 3a-h, sulfonamide derivatives 4a-h and amidine derivatives 5a, b; 6a-d are characterized by IR, 1H NMR, GC-MS spectral data and elemental analysis. Anti-inflammatory activity evaluation of 3a-h, 4a-d, g-h, 5a,b and 6a-c using carageenan induced paw oedema assay at 50 mg/kg p.o. has been carried out and compound 6a exhibited anti-inflammatory activity comparable to standard drug ibuprofen.en_US
dc.language.isoen_USen_US
dc.publisherCSIRen_US
dc.sourceIJC-B Vol.49B(08) [August 2010]en_US
dc.subjectThiazolineen_US
dc.subjectsulfonamideen_US
dc.subjectamidineen_US
dc.subjectanti-inflammatoryen_US
dc.titleSynthesis and anti-inflammatory activity evaluation of some sulfonamide and amidine derivatives of 4-aryl-3-(2 or 4-picolyl)-2-imino-4-thiazolinesen_US
dc.typeArticleen_US
Appears in Collections:IJC-B Vol.49B(08) [August 2010]

Files in This Item:
File Description SizeFormat 
IJCB 49B(8) 1076-1082.pdf100 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.